Navigation Links
United States Joins Suits Against Scios and Johnson & Johnson
Date:2/19/2009

s not cover drugs used for off-label uses unless such off-label use is established to be medically necessary. The federal health care programs -- in particular, Medicare -- paid substantial amounts for the serial outpatient off-label use of Natrecor.

In mid-2005, a panel of leading cardiologists told Scios that it should stop promoting the scheduled, serial outpatient use of Natrecor. Scios subsequently sent a letter to healthcare providers in which it acknowledged that there was insufficient clinical evidence supporting the safety and efficacy for scheduled, serial outpatient use of the drug. In 2007, Scios released the results of a clinical study that showed no significant benefits of serial outpatient Natrecor infusions.

The two separate civil False Claims Act suits -- called qui tam actions -- were filed by former Scios sales managers against Scios and Johnson & Johnson in the Northern District of California. The False Claims Act allows for private persons to file whistleblower suits to provide the government information about wrongdoing. Under the statute, if it is established that a person has submitted or caused others to submit false or fraudulent claims to the United States, the government can recover treble damages and $5,500 to $11,000 for each false or fraudulent claim filed. If the government is successful in resolving or litigating its claims, the whistleblower who initiated the action can receive a share of between 15 percent to 25 percent of the amount recovered.

The qui tam or whistleblower actions contain additional allegations. However, the United States is only intervening with regard to allegations that Scios marketed the drug Natrecor for serial infusions in the outpatient setting.

The investigation was conducted by the Civil Division of the U.S. Department of Justice, the U.S. Attorney's Office for the Northern District of California, the Federal Bureau of In
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
2. United States continues to have highest level of health spending
3. United Medicorp, Inc.s Shareholders Approve All Proposals
4. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
5. Medical Services International Received Its First Order for Testing By Regulatory Agencies in the United States
6. Peoples United Financial CEO Has Surgery
7. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
8. More Than 100 Organizations Call for a National AIDS Strategy to End the Epidemic in the United States
9. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
10. Universal Health Care Coverage in the United States
11. Women Deliver Conference to Feature United Nations Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... solution provider of IBM software products, announced today that it has received trademark ... the integration, display and detailed analysis of data from multiple sources providing an ...
(Date:7/1/2015)... ... 01, 2015 , ... A Priority Setting Partnership put in ... list they hope will guide future mesothelioma research. Surviving Mesothelioma has just posted ... , More than 450 mesothelioma patients, caregivers, and healthcare professionals answer the ...
(Date:7/1/2015)... ... 01, 2015 , ... Author Francesca Camp wasn’t always a steadfast supporter of plastic ... did her support of the practice; a terrible car accident years ago left her injured ... “Do I Need It ? (And What if I Do?): Answers to All Your Questions ...
(Date:7/1/2015)... ... July 01, 2015 , ... After conducting a ... Smith, Tri-City Medical Center in Oceanside, Calif., has hired Cheryle Bernard-Shaw ... leading organization-wide compliance adaptation efforts and growing a focus on risk management, Bernard-Shaw ...
(Date:7/1/2015)... ... July 01, 2015 , ... Incentivizing the use of generic drugs has been ... much as 80% or 90% off the prices for the brand-name products. But now ... mitigate the financial impact of these high-cost generic drugs. The July issue of Atlantic ...
Breaking Medicine News(10 mins):Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3
... [24-hour telephone access to language interpreters] to firms ... ... Washington, D.C. (Vocus) July 25, 2008 ... Inc.)], a leading provider of interpretation, translation, and language instruction ...
... be used to facilitate the planning and designing of new ... ... Hauppauge, NY (PRWEB) July 25, 2008 -- IVCi, LLC ( ... including high definition video conferencing, telepresence, audio visual integration, and ...
... July 24 Speaker Nancy Pelosi,released the following statement ... J. Hyde Global Leadership Against HIV/Aids, Tuberculosis, and,Malaria Reauthorization ... last,week, passed the House this evening by a vote ... for his signature into law., "Today the House ...
... by GPs and primary care docs, survey finds , , ... 2005, the number of prescriptions filled for antidepressant drugs ... a report released Thursday by the U.S. government. , ... Quality, of antidepressant prescriptions (not including refills) written after ...
... AMICAS, Inc. (Nasdaq: AMCS ),a leader in radiology ... report the company,s financial results,for the second quarter ending June ... (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ), ... August 5, 2008 -- Call begins promptly ...
... macular degeneration (AMD) is the commonest cause of ... in the regulation of the immune system influence ... University Clinic in Bonn, working in co-operation with ... now, for the first time, demonstrated that in ...
Cached Medicine News:Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2Health News:Pelosi Statement on House Passage of Global AIDS Legislation 2Health News:AMICAS Schedules Second Quarter Earnings Call 2Health News:Hyperactive immune resistance brings blindness in old age 2
(Date:7/1/2015)... , July 1, 2015  MEI Pharma, Inc. (Nasdaq: ... development of novel therapies for cancer, announced today that ... will present at the inaugural Cantor Fitzgerald Healthcare Conference on ... Le Parker Meridien in New York ... accessed at www.meipharma.com . A replay will be available ...
(Date:7/1/2015)... , July 1, 2015  LabStyle Innovations Corp. ... today announced the appointment of Todd Durniak as Senior ... Durniak brings to LabStyle over 20 years of ... as the Vice President and General Manager of ... delivering insulin supplies through durable medical equipment (DME) ...
(Date:7/1/2015)... 2015 Lupin , ... Total Number of MPP Sub-licensees to Fourteen Companies   ... announced the rapid expansion of its network of generic manufacturers ... to develop MPP-licensed antiretrovirals (ARVs). New companies Lupin and Strides ... new HIV medicine the MPP licensed from ViiV Healthcare two ...
Breaking Medicine Technology:MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference 2LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 2LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 3LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 4The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3
... Oct. 28 Adeona Pharmaceuticals, Inc., (AMEX: AEN ... Shareholders Meeting on Tuesday, November 2, from 9 a.m. to ... Ann Arbor, MI, 48108. During the Annual ... M.B.A., will give an update on the Company,s activities and ...
... DIEGO, Oct. 27 Gen-Probe Incorporated (Nasdaq: GPRO ... Oppenheimer 21st Annual Healthcare Conference in New York on November ... Lazard Capital Markets 7th Annual Healthcare Conference in New York ... presentations are scheduled to be webcast live and may be ...
Cached Medicine Technology:Gen-Probe to Webcast Two Upcoming Investor Presentations 2
... warfarin for use by healthcare professionals and ... easy-to-read back-lit display and an operator rechargeable ... the ability to auto-send results to a ... LIS or EMR database through a clinical ...
... easiest test to use on the market. Rapid ... hands-on time. Critical care instructions can be provided ... pediatrician's office. Valuable information can be obtained prior ... the focus can be on the results and ...
The INRatio meter is a diagnostic Point Of Care system that provides Prothrombin Time (PT) and International Normalized Ratio (INR) results using one drop of fresh capillary whole blood from a finger...
... for the rapid detection of 5 commonly abused drugs ... test cup and test card. After the urine is ... sealed with a lid. Results are read 3-8 minutes ... card to read the result. The urine sample cup ...
Medicine Products: